The Workforce AI Index · Healthcare
AbbVie Inc. (ABBV)
Drug maker, one pattern. Read October 1, 2026 from the annual report for the period ending 2025-12-31, filed 2026-02-20. Ranked 24 of the 27 Healthcare companies read so far, by the share within reach now: the sector.
The filing states approximately 57,000 employees in over 70 countries and one biopharmaceutical business, so one pattern carries the workforce (c).
The figures on this page come from the company's own annual report and from BLS staffing patterns for its industries, never from a roster. They are estimates with a stated method. Nothing here says what the company will do: within reach is not a forecast of jobs lost or of savings.
What follows from the reading
Share of working time within reach of AI, on the long-run pace at four in five: 17% now, 33% at the end of 2027, 40% at the end of 2028, 44% at the end of 2030. By the patterns, the work is about 44% desk work, 14% people work and 43% body work. These are the site's industry estimates weighted by the shares below: estimates with a stated method and range, not a forecast of what the company will do. By the same patterns, at the end of 2028 about 56% of the working time stays with people (conversation, in-person and hands-on work), 37% becomes checking a model's work and 4% could be handed over with lighter checks, from the industries' own figures, not the company's roles.
Headcount
57,000 employees as of 2025-12-31 (stated). The filing states over 70 countries and gives no count by country; the United States is 95% of revenue.
The filing: “AbbVie employed approximately 57,000 employees in over 70 countries as of December 31, 2025.”
The workforce as industry patterns
| Pattern | Share | Reason, from the filing |
|---|---|---|
| Pharmaceutical and Medicine Manufacturing | 100% | By description (c): a biopharmaceutical company whose products, from immunology to aesthetics, are all pharmaceutical making, with no count by kind of work. |
What the filing says about the workforce: Approximately 57,000 employees in over 70 countries, up from 55,000; significant investment in foundational AI skills for employees; professional development programs of up to three years.
Companies read with the same leading pattern
Other companies whose largest staffing pattern is also Pharmaceutical and Medicine Manufacturing, largest first, each read from its own annual report. Within reach now and at the end of 2028, long-run pace, four in five.
- Johnson & Johnson (JNJ, 140,800 employees)18% now, 38% by 2028
- Thermo Fisher Scientific Inc. (TMO, 125,000 employees)19% now, 48% by 2028
- Merck & Co., Inc. (MRK, 75,000 employees)17% now, 40% by 2028
- Pfizer Inc. (PFE, 75,000 employees)17% now, 40% by 2028
What the filing says about AI
5 sentences in the filing name AI. The filing names AI in 5 sentences: foundational AI skills built across its employees, AI used in select applications to support operations, and the risk of failing to adopt emerging technologies such as AI.
- “AbbVie has invested significantly in equipping employees with foundational artificial intelligence (AI) skills, 13 | 2025 Form 10-K reflecting both the opportunities AI presents and its commitment to supporting employees as work evolves.”
- “AbbVie depends on information technology and a failure of, or significant disruption to, those systems, or a failure to adequately adopt emerging technologies such as artificial intelligence, could have a material adverse effect on AbbVie's business.”
- “Additionally, AbbVie utilizes AI and other emerging technologies in select applications to support its operations.”
- “These technologies may present opportunities for AbbVie's business but may also entail risks, including that AI-generated analyses utilized by AbbVie could be deficient or exacerbate regulatory, cybersecurity or other significant risks.”
- “Further, our failure to effectively implement these technologies could hinder our ability to compete, as competitors' advancements in AI may lead to more efficient operations.”
Headcount by filing year
As reported in each year's annual report, with the filing. A year marked not read had no figure the reading could take from the report's text.
| Period | Employees | Filed | Filing |
|---|---|---|---|
| 2025-12-31 | 57,000 | 2026-02-20 | 10-K |
| 2024-12-31 | 55,000 | 2025-02-14 | 10-K |
| 2023-12-31 | 50,000 | 2024-02-20 | 10-K |
| 2022-12-31 | 50,000 | 2023-02-17 | 10-K |
| 2021-12-31 | 50,000 | 2022-02-18 | 10-K |
| 2020-12-31 | 47,000 | 2021-02-19 | 10-K |
| 2019-12-31 | 30,000 | 2020-02-21 | 10-K |
| 2018-12-31 | 30,000 | 2019-02-27 | 10-K |
| 2017-12-31 | 29,000 | 2018-02-16 | 10-K |
| 2016-12-31 | 30,000 | 2017-02-17 | 10-K |
| 2015-12-31 | 28,000 | 2016-02-19 | 10-K |
| 2014-12-31 | 26,000 | 2015-02-20 | 10-K |
| 2013-12-31 | 25,000 | 2014-02-21 | 10-K |
| 2012-12-31 | 21,500 | 2013-03-15 | 10-K |
Limits of this reading
- The filing counts no people by kind of work or by country; the single pattern rests on its description (c).
- The U.S. share is not stated.
Source: the company's annual report on EDGAR, accession 0001551152-26-000008, the filing. Read by Claude Fable 5.1 under rubric version 1, by the method. A company can write to info@stratussc.com to have its reading checked against its filing.
Questions about this company
- How much of AbbVie Inc.'s working time is within reach of AI?
- An estimated 17% now and 40% by the end of 2028, on METR's long-run pace at four in five, from the workforce AbbVie Inc.'s own annual report describes and BLS staffing patterns for its industries, never from a roster. It is an estimate with a stated method. It is not a forecast of jobs lost or of savings, and it says nothing about what the company will do.
- How many people does AbbVie Inc. employ?
- 57,000 as of December 31, 2025, as its annual report for the period ending December 31, 2025 states.
- What kinds of work make up AbbVie Inc.'s workforce?
- Read from its annual report as a blend of 1 industry staffing pattern, the largest Pharmaceutical and Medicine Manufacturing; by those patterns the work is about 44% desk work, 14% people work and 43% body work. Each share has a one-sentence reason on this page that can be checked against the filing.
- What does AbbVie Inc.'s annual report say about AI?
- 5 sentences in the filing name AI. They are counted and quoted on this page, never judged: a count says how much a filing talks about AI, not what the company does with it.
- How is this estimated?
- Claude Fable 5.1 read the annual report under the Index's written rubric (version 1) on October 1, 2026: the stated headcount, the share in the U.S. when stated, and the workforce as a blend of industry staffing patterns. The estimates are the site's industry estimates weighted by those shares, from O*NET tasks with estimated lengths and METR's measurements of how long a task AI models can finish. A company can write to info@stratussc.com to have its reading checked against its filing.
Embed these figures on your site
A small card with the share of working time within reach now and at the end of 2027, 2028 and 2030, the date and a link back. Free under CC BY 4.0; the card carries the credit.